BioPharm International OnDemand Digital Archives of Past Web Seminars
Interactive, educational web seminars. It’s simple: pick the event you want to purchase access to. We will email you reminders of the time and date. Then just log on and experience global industry leaders presenting conference quality content on today’s hot topics without leaving your desk.
Your Purchase Package Includes:
ARCHIVED WEB SEMINARS:
FEBRUARY
IT Infrastructure and Network Qualification:Introduction and Strategies for Compliance and System Uptime
Ludwig Huber, Ph.D., Worldwide Compliance Program Manager, Agilent Technologies
> Sign Up NowAvailable through May 26, 2008
JANUARY
UHPLC: The Ideal MS Inlet (6 of 6)
Michael Swartz, Ph.D., Research Director, Synomics Pharma
> Sign Up NowAvailable through April 18, 2008PAT Equipment Qualification and Method Validation (5 of 5)
Dr. Frederick Long, President, Spectroscopic Solutions, LLC
> Sign Up NowAvailable through April 23, 2008
DECEMBER
PAT Equipment Qualification & Method Validation (4 of 5)
Dr. Frederick Long, President, Spectroscopic Solutions, LLC
> Sign Up NowAvailable through April 23, 2008
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
The Future of Cleanroom Construction: How Hybrid Solutions are Changing the Game
May 14th 2025Imagine a world where cleanroom facilities—essential for pharmaceutical manufacturing, biotechnology, and high-tech industries—are built with unparalleled speed, precision, and efficiency. That world is here, thanks to the hybrid construction approach. By blending traditional stick-built methods with modular and prefabricated solutions, companies are overcoming the limitations of conventional construction while ensuring compliance with stringent industry regulations. In this interview, we explore how hybrid cleanroom construction is transforming the industry, offering faster project timelines, improved quality control, and significant cost advantages. Join us as we delve into this game-changing approach with industry experts who are leading the charge in revolutionizing cleanroom infrastructure.
Mastering Antibody-Drug Conjugates
December 19th 2024In this episode, we explore BIOVECTRA’s capabilities in antibody-drug conjugate (ADC) manufacturing, from complex conjugation chemistry to synthesis of highly potent payloads. We’ll also showcase how BIOVECTRA’s extensive experience in complex chemistries and specialized small molecule manufacturing gives them a unique perspective, strengthening their approach to ADC production and ensuring clients receive custom solutions across all project stages.